(EXLS) ExlService Holdings - Ratings and Ratios
Analytics, Operations, Insurance, Healthcare, Banking
EXLS EPS (Earnings per Share)
EXLS Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 28.0% |
| Value at Risk 5%th | 41.7% |
| Reward | |
|---|---|
| Sharpe Ratio | -0.47 |
| Alpha | -24.12 |
| Character | |
|---|---|
| Hurst Exponent | 0.401 |
| Beta | 0.863 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.62% |
| Mean DD | 13.67% |
Description: EXLS ExlService Holdings November 05, 2025
ExlService Holdings, Inc. (NASDAQ: EXLS) delivers data-analytics-driven digital operations and automation solutions across four primary segments: Insurance; Healthcare & Life Sciences; Banking, Capital Markets & Diversified Industries; and International Growth Markets. Its service portfolio spans end-to-end claim processing, underwriting support, premium administration, sub-rogation platforms (Subrosource), and SaaS-based customer acquisition tools (LifePRO, Life Digital Suite), leveraging AI, machine-learning, and advanced automation.
In FY 2023 the company reported revenue of roughly $1.2 billion, representing a 5 % year-over-year increase, while operating margin hovered near 6 %. Growth is being propelled by rising demand for cost-containment solutions in insurance and healthcare-sectors that are grappling with higher claim volumes and regulatory pressure to improve payment integrity. Additionally, the broader data-processing outsourcing market is expanding at a 7-8 % CAGR, driven by enterprises’ accelerated digital transformation initiatives.
Exl’s strategic focus on predictive and prescriptive analytics for customer acquisition and lifecycle management positions it to capture upside from the ongoing shift toward AI-enabled operational efficiency across its core verticals. For a deeper dive into EXLS’s valuation metrics and peer comparisons, you might find ValueRay’s analyst toolkit useful.
EXLS Stock Overview
| Market Cap in USD | 6,215m |
| Sub-Industry | Data Processing & Outsourced Services |
| IPO / Inception | 2006-10-20 |
EXLS Stock Ratings
| Growth Rating | -8.52% |
| Fundamental | 85.5% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -25.7% |
| Analyst Rating | 4.30 of 5 |
EXLS Dividends
Currently no dividends paidEXLS Growth Ratios
| Growth Correlation 3m | -73.1% |
| Growth Correlation 12m | -69.5% |
| Growth Correlation 5y | 86.3% |
| CAGR | 2.51% |
| CAGR/Max DD Calmar Ratio | 0.08 |
| CAGR/Mean DD Pain Ratio | 0.18 |
| Current Volume | 1558.1k |
| Average Volume | 1269.4k |
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income (241.4m TTM) > 0 and > 6% of Revenue (6% = 121.6m TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 4.48pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 28.86% (prev 29.00%; Δ -0.13pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 338.7m > Net Income 241.4m (YES >=105%, WARN >=100%) |
| Net Debt (-75.8m) to EBITDA (399.3m) ratio: -0.19 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.91 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (161.7m) change vs 12m ago -0.90% (target <= -2.0% for YES) |
| Gross Margin 38.24% (prev 37.24%; Δ 1.00pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 121.2% (prev 110.0%; Δ 11.21pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 17.80 (EBITDA TTM 399.3m / Interest Expense TTM 18.5m) >= 6 (WARN >= 3) |
Altman Z'' 8.06
| (A) 0.34 = (Total Current Assets 891.9m - Total Current Liabilities 307.0m) / Total Assets 1.73b |
| (B) 0.85 = Retained Earnings (Balance) 1.47b / Total Assets 1.73b |
| warn (B) unusual magnitude: 0.85 — check mapping/units |
| (C) 0.20 = EBIT TTM 328.6m / Avg Total Assets 1.67b |
| (D) 1.67 = Book Value of Equity 1.30b / Total Liabilities 781.2m |
| Total Rating: 8.06 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 85.45
| 1. Piotroski 8.50pt = 3.50 |
| 2. FCF Yield 4.85% = 2.43 |
| 3. FCF Margin 14.16% = 3.54 |
| 4. Debt/Equity 0.09 = 2.50 |
| 5. Debt/Ebitda -0.19 = 2.50 |
| 6. ROIC - WACC (= 10.78)% = 12.50 |
| 7. RoE 24.42% = 2.03 |
| 8. Rev. Trend 99.16% = 7.44 |
| 9. EPS Trend -19.61% = -0.98 |
What is the price of EXLS shares?
Over the past week, the price has changed by +0.97%, over one month by -5.83%, over three months by -5.99% and over the past year by -15.69%.
Is ExlService Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EXLS is around 33.28 USD . This means that EXLS is currently overvalued and has a potential downside of -15.83%.
Is EXLS a buy, sell or hold?
- Strong Buy: 5
- Buy: 3
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the EXLS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 52.3 | 32.2% |
| Analysts Target Price | 52.3 | 32.2% |
| ValueRay Target Price | 37.3 | -5.6% |
EXLS Fundamental Data Overview November 04, 2025
P/E Trailing = 26.4595
P/E Forward = 20.0
P/S = 3.0667
P/B = 6.6131
P/EG = 1.3346
Beta = 0.863
Revenue TTM = 2.03b USD
EBIT TTM = 328.6m USD
EBITDA TTM = 399.3m USD
Long Term Debt = 283.6m USD (from longTermDebt, last fiscal year)
Short Term Debt = 24.1m USD (from shortTermDebt, last quarter)
Debt = 84.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -75.8m USD (from netDebt column, last quarter)
Enterprise Value = 5.91b USD (6.21b + Debt 84.5m - CCE 390.1m)
Interest Coverage Ratio = 17.80 (Ebit TTM 328.6m / Interest Expense TTM 18.5m)
FCF Yield = 4.85% (FCF TTM 286.9m / Enterprise Value 5.91b)
FCF Margin = 14.16% (FCF TTM 286.9m / Revenue TTM 2.03b)
Net Margin = 11.91% (Net Income TTM 241.4m / Revenue TTM 2.03b)
Gross Margin = 38.24% ((Revenue TTM 2.03b - Cost of Revenue TTM 1.25b) / Revenue TTM)
Gross Margin QoQ = 38.51% (prev 37.75%)
Tobins Q-Ratio = 3.41 (Enterprise Value 5.91b / Total Assets 1.73b)
Interest Expense / Debt = 5.82% (Interest Expense 4.92m / Debt 84.5m)
Taxrate = 22.03% (16.5m / 74.7m)
NOPAT = 256.2m (EBIT 328.6m * (1 - 22.03%))
Current Ratio = 2.91 (Total Current Assets 891.9m / Total Current Liabilities 307.0m)
Debt / Equity = 0.09 (Debt 84.5m / totalStockholderEquity, last quarter 952.4m)
Debt / EBITDA = -0.19 (Net Debt -75.8m / EBITDA 399.3m)
Debt / FCF = -0.26 (Net Debt -75.8m / FCF TTM 286.9m)
Total Stockholder Equity = 988.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.93% (Net Income 241.4m / Total Assets 1.73b)
RoE = 24.42% (Net Income TTM 241.4m / Total Stockholder Equity 988.8m)
RoCE = 25.83% (EBIT 328.6m / Capital Employed (Equity 988.8m + L.T.Debt 283.6m))
RoIC = 19.92% (NOPAT 256.2m / Invested Capital 1.29b)
WACC = 9.14% (E(6.21b)/V(6.30b) * Re(9.20%) + D(84.5m)/V(6.30b) * Rd(5.82%) * (1-Tc(0.22)))
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.56%
[DCF Debug] Terminal Value 77.77% ; FCFE base≈249.9m ; Y1≈308.2m ; Y5≈525.9m
Fair Price DCF = 45.58 (DCF Value 7.23b / Shares Outstanding 158.7m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -19.61 | EPS CAGR: -34.86% | SUE: 1.27 | # QB: 5
Revenue Correlation: 99.16 | Revenue CAGR: 13.41% | SUE: 2.44 | # QB: 3
Additional Sources for EXLS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle